Questions and Answers: NDMA Impurities in Ranitidine (Commonly Known as Zantac)

Questions and Answers: NDMA Impurities in Ranitidine (Commonly Known as Zantac) October 11, 2019 What patients should know about NDMA impurities in ranitidine Not all ranitidine medicines marketed in the U.S. are being recalled. FDA does not have

FDA Approves Scenesse FDA Approves Scenesse (afamelanotide) for Prevention of Phototoxicity in Erythropoietic Protoporphyria

FDA Approves Scenesse FDA Approves Scenesse (afamelanotide) for Prevention of Phototoxicity in Erythropoietic Protoporphyria October 08, 2019 -- The U.S. Food and Drug Administration today granted approval to Scenesse (afamelanotide) to increase pain-

FDA Approves Beovu (brolucizumab-dbll) for the Treatment of Wet Age-Related Macular Degeneration (AMD)

FDA Approves Beovu (brolucizumab-dbll) for the Treatment of Wet Age-Related Macular Degeneration (AMD) EAST HANOVER, N.J., Oct. 8, 2019 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Beovu (brolucizum

Holiday notice

FDA Approves Jynneos FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults

FDA Approves Jynneos FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults COPENHAGEN, Denmark, September 24, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today an

FDA Alerts Health Care Professionals and Patients to Voluntary Recall of Ranitidine Medicines

FDA Alerts Health Care Professionals and Patients to Voluntary Recall of Ranitidine Medicines September 27, 2019 -- The U.S. Food and Drug Administration is alerting health care professionals and patients to a voluntary recall of over-the-counter (OTC) r